Helius Medical Technologies Inc Class A (HSDT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Helius Medical Technologies Inc Class A (HSDT) has a cash flow conversion efficiency ratio of 0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.04 Million) by net assets ($-152.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Helius Medical Technologies Inc Class A for the company's overall valuation and market capitalisation.
Helius Medical Technologies Inc Class A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Helius Medical Technologies Inc Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Helius Medical Technologies Inc Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Helius Medical Technologies Inc Class A ranked by their cash flow conversion efficiency. Explore Helius Medical Technologies Inc Class A cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Greenheart Gold Inc.
V:GHRT
|
-0.089x |
|
Clearwise AG
DU:ABO
|
0.058x |
|
TVS Electronics Limited
NSE:TVSELECT
|
-0.125x |
|
ATHOS IMMO (IJM.SG)
STU:IJM
|
N/A |
|
Morn Sun Feed Mill Corp
TWO:1240
|
0.009x |
|
ST Dupont
PA:DPT
|
-0.078x |
|
VLS Finance Limited
NSE:VLSFINANCE
|
-0.002x |
|
FM Global Logistics Holdings Bhd
KLSE:7210
|
0.028x |
Annual Cash Flow Conversion Efficiency for Helius Medical Technologies Inc Class A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Helius Medical Technologies Inc Class A from 2013 to 2024. View current stock price of Helius Medical Technologies Inc Class A for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.06 Million | $-11.04 Million | -10.426x | -135.22% |
| 2023-12-31 | $2.35 Million | $-10.42 Million | -4.432x | -152.47% |
| 2022-12-31 | $8.15 Million | $-14.31 Million | -1.756x | -47.60% |
| 2021-12-31 | $11.26 Million | $-13.39 Million | -1.189x | +60.78% |
| 2020-12-31 | $3.87 Million | $-11.74 Million | -3.032x | +15.74% |
| 2019-12-31 | $5.83 Million | $-21.00 Million | -3.599x | -80.74% |
| 2018-12-31 | $9.85 Million | $-19.62 Million | -1.991x | -177.17% |
| 2017-12-31 | $-7.49 Million | $-19.32 Million | 2.580x | -99.47% |
| 2016-12-31 | $-16.19K | $-7.94 Million | 490.176x | -0.01% |
| 2015-12-31 | $-16.19K | $-7.94 Million | 490.206x | +12020.05% |
| 2014-12-31 | $-1.56 Million | $-6.32 Million | 4.045x | +210.83% |
| 2013-12-31 | $-267.98K | $-348.70K | 1.301x | -- |
About Helius Medical Technologies Inc Class A
Solana Company operates as a listed digital asset treasury. It enhances SOL per share on the commercially viable blockchain for decentralized finance and consumer applications. The company is headquartered in Newtown, Pennsylvania.